uracil has been researched along with Atrial Fibrillation in 4 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we explored whether alogliptin, a dipeptidyl peptidase-4 inhibitor, can prevent mitochondrial dysfunction and atrial remodeling in a diabetic rabbit model." | 7.85 | Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits. ( Jiang, N; Li, G; Li, J; Liang, X; Liu, T; Qiu, J; Tse, G; Wang, X; Yang, Y; Zhang, X; Zhang, Z; Zhao, Y, 2017) |
| " In this study, we explored whether alogliptin, a dipeptidyl peptidase-4 inhibitor, can prevent mitochondrial dysfunction and atrial remodeling in a diabetic rabbit model." | 3.85 | Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits. ( Jiang, N; Li, G; Li, J; Liang, X; Liu, T; Qiu, J; Tse, G; Wang, X; Yang, Y; Zhang, X; Zhang, Z; Zhao, Y, 2017) |
| "We investigated the effects of a DPP-4 inhibitor, alogliptin, on atrial fibrillation (AF) in a rabbit model of heart failure caused by ventricular tachypacing (VTP)." | 3.81 | Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits. ( Hirai, M; Inden, Y; Murohara, T; Shimano, M; Takefuji, M; Tsuji, Y; Yamamoto, T; Yanagisawa, S; Yoshida, N, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ismayl, M | 1 |
| Abbasi, MA | 1 |
| Marar, R | 1 |
| Geske, JB | 1 |
| Gersh, BJ | 1 |
| Anavekar, NS | 1 |
| Nabavizadeh, P | 1 |
| Steen, DL | 1 |
| Zhang, X | 1 |
| Zhang, Z | 1 |
| Zhao, Y | 1 |
| Jiang, N | 1 |
| Qiu, J | 1 |
| Yang, Y | 1 |
| Li, J | 1 |
| Liang, X | 1 |
| Wang, X | 1 |
| Tse, G | 1 |
| Li, G | 1 |
| Liu, T | 1 |
| Yamamoto, T | 1 |
| Shimano, M | 1 |
| Inden, Y | 1 |
| Takefuji, M | 1 |
| Yanagisawa, S | 1 |
| Yoshida, N | 1 |
| Tsuji, Y | 1 |
| Hirai, M | 1 |
| Murohara, T | 1 |
1 review available for uracil and Atrial Fibrillation
| Article | Year |
|---|---|
Mavacamten Treatment for Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Atrial Fibrillation; Benzylamines; Cardiomyopathy, Hypertrophic; Humans; Randomized Controlled Trial | 2023 |
3 other studies available for uracil and Atrial Fibrillation
| Article | Year |
|---|---|
Highlights from the European society of cardiology congress 2020.
Topics: Atrial Fibrillation; Benzhydryl Compounds; Benzylamines; Cardiomyopathy, Hypertrophic; Cardiovascula | 2021 |
Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits.
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Diabetes Mellitus, Experimental; Dipeptidyl-Peptida | 2017 |
Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits.
Topics: Animals; Atrial Fibrillation; Blotting, Western; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; E | 2015 |